Refreshing results…
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
Download from doi.orgINK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
UploadTERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
Download from doi.orgAKT1 E17K inhibits cancer cell migration by abrogating β-catenin signaling
Download from aacrjournals.orgThe genomic landscape of metastatic histologic special types of invasive breast cancer
Download from doi.orgMutant SF3B1 promotes AKT and NF-kB driven mammary tumorigenesis
Download from doi.orgDouble PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
UploadLoss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
UploadNeratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
UploadKMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
Download from www.nature.comMissing publications? Search for publications with a matching author name.